Zelestra Launches 162 MW Solar Construction in Spain

• Zelestra ignites renewable energy in Spain! Three solar projects are set to power pharmaceutical supply chains and create 400 jobs by 2026. Solar energy meets sustainability!

Zelestra, a Spanish renewables firm, has commenced construction on three solar projects in Castilla-La Mancha, Spain, with a combined capacity of 162 MW. The Belinchon I, II, and III sites are anticipated to be operational by the second quarter of 2026, generating over 400 jobs during the construction phase.

These solar projects are part of Zelestra’s Energize programme, designed to enhance renewable energy access for pharmaceutical supply chains. The company has secured power purchase agreements (PPA) for 305 GWh of renewable energy annually with firms including Takeda and Teva. Zelestra, backed by EQT, manages a global portfolio of 27 GW across 13 countries.

How will Zelestra's solar projects impact renewable energy in pharmaceutical supply chains?

The Impact of Zelestra's Solar Projects on Renewable Energy in Pharmaceutical Supply Chains

• Increased Renewable Energy Access: By providing a significant amount of renewable energy through its solar projects, Zelestra enables pharmaceutical companies to transition away from fossil fuels, lowering their carbon footprints and aligning with global sustainability goals.
• Stability in Energy Costs: The power purchase agreements (PPAs) secured by Zelestra offer predictability and stability in energy costs for companies like Takeda and Teva. This can help pharmaceutical firms manage expenses more accurately and allocate resources more efficiently.
• Enhancing Corporate Sustainability Goals: The collaboration with Zelestra supports the pharmaceutical industry’s commitment to reducing greenhouse gas emissions. Companies can use their renewable energy sourcing as a key indicator of their environmental performance and attract eco-conscious investors.
• Supply Chain Resilience: With increased reliance on renewable energy, pharmaceutical companies can reduce their exposure to energy price volatility and supply chain disruptions associated with non-renewable energy sources, enhancing overall supply chain resilience.
• Local Economic Development: The construction of solar projects leads to job creation, as demonstrated by the projected 400 jobs during the construction phase. This not only supports the local economy in Castilla-La Mancha but also enhances Zelestra's reputation and relations within the community.
• Innovation and Technological Advancements: Collaborating with innovative firms like Zelestra can push pharmaceutical companies towards adopting advanced energy solutions and technologies, fostering a culture of innovation within their operations.
• Compliance with Regulatory Standards: As governments increasingly implement stringent regulations regarding energy usage and emissions, sourcing renewable energy through projects like those of Zelestra can help pharmaceutical companies maintain compliance and avoid potential fines.
• Global Portfolio Synergy: Zelestra's extensive global portfolio of 27 GW allows pharmaceutical companies to adopt best practices and benchmarks in renewable energy usage that can be shared across different regions and projects, potentially leading to more widespread adoption of green energy solutions.
• Long-Term Environmental Impact: By integrating renewable energy sources into their supply chains, pharmaceutical companies not only mitigate their operational impacts but also contribute to broader environmental conservation efforts, leading to a sustainable future for the industry.
• Partnership Opportunities: The establishment of significant solar energy projects opens doors for collaborations among renewable energy providers, pharmaceutical companies, and government entities, fostering partnerships that can drive further investment and innovation in sustainable practices.
• Consumer Trust and Brand Loyalty: By aligning with renewable energy initiatives, pharmaceutical companies can enhance their brand image, build consumer trust, and foster loyalty among consumers who prioritize sustainability in their purchasing decisions.